-10%
Suvirus 400mg Tablet
Suvirus is a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor indicated for the treatment of chronic hepatitis C (CHC) infection as a component of a combination antiviral treatment regimen.
:
Out of stock
In stock – ready to ship
Delivery
Inside Dhaka: 1–2 days · Outside Dhaka: 2–4 days
Cash on Delivery
Pay when you receive your order.
Returns
Easy 7-day return & exchange
- Category
- Tablet & Capsules
- Brand
- Square Pharmaceuticals PLC
Product details
Suvirus 400mg Tablet
Suvirus is a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor indicated for the treatment of chronic hepatitis C (CHC) infection as a component of a combination antiviral treatment regimen.
The following points should be considered when initiating treatment with Suvirus:
- Monotherapy of Suvirus is not recommended for treatment of CHC.
- Treatment regimen and duration are dependent on both viral genotype and patient population.
- Treatment response varies based on baseline host and viral factor.
Pharmacology
Sofosbuvir is nucleotide analog inhibitor, which specifically inhibits HCV NS5B (non-structural protein 5B) RNA-dependent RNA polymerase. Following intracellular metabolism to form the pharmacologically active uridine analog triphosphate (GS-461203), sofosbuvir incorporates into HCV RNA by the NS5B polymerase and acts as a chain terminator.
Interaction
Reduced therapeutic effect with drugs that are potent P-gp inducers in the intestine (eg rifampicin, St. John's wort, carbamazepine & phenytoin), modafinil, phenobarb/ oxcarbazepine, rifabutin/ rifapentine. P-gp &/or BCRP inhibitors. May result in serious symptomatic bradycardia when co-administered with amiodarone in combination with another direct acting antiviral.
Contraindications
When Sofosbivur is used in combination with Ribavirin or Peginterferon alfa/ Ribavirin, the contraindications applicable to those agents are applicable to combination therapies.
Side Effects
The most common adverse events (incidence greater than or equal to 20%, all grades) observed with Suvirus in combination with Ribavirin were fatigue and headache.
Pregnancy & Lactation
Pregnancy Category B: Sofosbuvir There are no adequate and well-controlled studies with Sofosbuvir in pregnant women.
Nursing Mothers: It is not known whether Sofosbuvir and its metabolites are present in human breast milk.
Precautions & Warnings
Bradycardia with amiodarone co-administration: Serious symptomatic bradycardia may occur in patients taking amiodarone and Suvirus in combination with another direct acting antiviral (DAA), particularly in patients also receiving beta blockers, or those with underlying cardiac comorbidities and/or advanced liver disease.
Use in Special Populations
Pediatric Use: Safety and effectiveness of Suvirus in children less than 18 years of age have not been established.
Geriatric Use: Suvirus was administered to 90 subjects aged 65 and over. The response rates observed for subjects over 65 years of age were similar to that of younger subjects across treatment groups. No dose adjustment of Suvirus is warranted in geriatric patients.
Overdose Effects
The highest dose of Suvirus is a single dose of Suvirus 1200 mg. No specific antidote is available for overdose treatment. Treatment of overdose with Suvirus consists of general supportive measures including monitoring of vital signs as well as observation of the clinical status of the patient.
Therapeutic Class
Hepatic viral infections (Hepatitis C)
Storage Conditions
Keep out of the reach of children. Keep in a cool & dry place. Protect from light.
0 reviews
⭐
No reviews yet
Bought this product? Share your experience to help others.
You may also like
Suvirus 400mg Tablet
৳7,200